Indivior PLC (NASDAQ:INDV) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Indivior PLC (NASDAQ:INDV) have received an average rating of “Moderate Buy” from the eight analysts that are covering the company, MarketBeat reports. Two analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $22.00.

A number of analysts recently commented on the company. Jefferies Financial Group started coverage on Indivior in a research report on Tuesday, July 22nd. They issued a “buy” rating and a $20.00 target price for the company. Craig Hallum boosted their price objective on Indivior from $27.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, August 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Indivior in a research note on Wednesday, October 8th. HC Wainwright assumed coverage on shares of Indivior in a research note on Wednesday, August 6th. They set a “buy” rating and a $27.00 price target for the company. Finally, Zacks Research lowered shares of Indivior from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 3rd.

Institutional Investors Weigh In On Indivior

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Indivior by 16.0% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,820 shares of the company’s stock worth $71,000 after acquiring an additional 666 shares in the last quarter. CWM LLC bought a new stake in Indivior during the 3rd quarter worth approximately $25,000. Raymond James Financial Inc. bought a new stake in Indivior during the 2nd quarter worth approximately $26,000. Campbell & CO Investment Adviser LLC increased its holdings in Indivior by 3.5% during the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 53,782 shares of the company’s stock worth $1,297,000 after purchasing an additional 1,834 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd increased its holdings in Indivior by 17.4% during the 2nd quarter. Y Intercept Hong Kong Ltd now owns 25,443 shares of the company’s stock worth $375,000 after purchasing an additional 3,769 shares in the last quarter. 60.33% of the stock is owned by institutional investors.

Indivior Trading Up 1.3%

INDV opened at $25.24 on Thursday. Indivior has a 1-year low of $7.62 and a 1-year high of $25.49. The company has a market cap of $3.48 billion, a P/E ratio of 40.71 and a beta of 0.70. The company has a fifty day moving average price of $24.04 and a two-hundred day moving average price of $17.92.

Indivior (NASDAQ:INDV) last issued its earnings results on Thursday, July 31st. The company reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.25. Indivior had a negative return on equity of 86.28% and a net margin of 6.65%.The business had revenue of $302.00 million during the quarter, compared to analyst estimates of $239.43 million. On average, research analysts forecast that Indivior will post 1.22 EPS for the current fiscal year.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.